SalivaTech

Salivatech is a pioneering company in the field of saliva-based diagnostics, focusing on early detection of cancers such as pancreatic, oral, and breast cancer. Utilizing advanced metabolomics, which is the study of small molecules called metabolites within cells, biofluids, tissues, or organisms, Salivatech identifies specific metabolic profiles that indicate the presence of high-risk cancer patients. The company serves healthcare providers, research institutions, and potentially patients directly, operating primarily in the medical diagnostics market. Its business model revolves around the development and sale of diagnostic kits and services, generating revenue through product sales and possibly through partnerships or licensing agreements. Salivatech's innovative approach aims to provide non-invasive, accurate, and early cancer detection solutions, thereby improving patient outcomes and reducing healthcare costs.

Keywords: saliva diagnostics, cancer detection, metabolomics, non-invasive, healthcare, medical diagnostics, pancreatic cancer, oral cancer, breast cancer, early detection.